Cited 0 time in
The Mid-term Outcomes of Posterior or Posterolateral Fusion Using Escherichia Coli-Derived Recombinant Human Bone Morphogenetic Protein2(E. BMP-2) : Minimum 3-Years Follow-up
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 강창남 | - |
| dc.date.accessioned | 2024-12-03T07:30:27Z | - |
| dc.date.available | 2024-12-03T07:30:27Z | - |
| dc.date.issued | 2024-05-23 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/199528 | - |
| dc.title | The Mid-term Outcomes of Posterior or Posterolateral Fusion Using Escherichia Coli-Derived Recombinant Human Bone Morphogenetic Protein2(E. BMP-2) : Minimum 3-Years Follow-up | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | KSSS 2024 | - |
| dc.citation.conferencePlace | 롯데호텔 서울 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
